These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 20569068)

  • 21. OnabotulinumtoxinA for the Treatment of Poststroke Distal Lower Limb Spasticity: A Randomized Trial.
    Wein T; Esquenazi A; Jost WH; Ward AB; Pan G; Dimitrova R
    PM R; 2018 Jul; 10(7):693-703. PubMed ID: 29330071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.
    Yablon SA; Brashear A; Gordon MF; Elovic EP; Turkel CC; Daggett S; Liu J; Brin MF
    Clin Ther; 2007 Apr; 29(4):683-90. PubMed ID: 17617291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Randomized, Double-Blind, Active Control, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Liztox
    Ye DH; Chun MH; Park YG; Paik NJ; Lee SU; Yoo SD; Kim DY
    Toxins (Basel); 2023 Dec; 15(12):. PubMed ID: 38133201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
    Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P; Denis A; Gasq D; Chaleat-Valayer E; Yelnik A; Colin C; ; Pérennou D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):207-213. PubMed ID: 31229700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined therapeutic application of botulinum toxin type A, low-frequency rTMS, and intensive occupational therapy for post-stroke spastic upper limb hemiparesis.
    Kakuda W; Abo M; Momosaki R; Yokoi A; Fukuda A; Ito H; Tominaga A; Umemori T; Kameda Y
    Eur J Phys Rehabil Med; 2012 Mar; 48(1):47-55. PubMed ID: 22071503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke.
    Childers MK; Brashear A; Jozefczyk P; Reding M; Alexander D; Good D; Walcott JM; Jenkins SW; Turkel C; Molloy PT
    Arch Phys Med Rehabil; 2004 Jul; 85(7):1063-9. PubMed ID: 15241751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of letibotulinumtoxinA(BOTULAX®) in treatment of post stroke upper limb spasticity: a randomized, double blind, multi-center, phase III clinical trial.
    Do KH; Chun MH; Paik NJ; Park YG; Lee SU; Kim MW; Kim DK
    Clin Rehabil; 2017 Sep; 31(9):1179-1188. PubMed ID: 28118733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke.
    Santamato A; Panza F; Intiso D; Baricich A; Picelli A; Smania N; Fortunato F; Seripa D; Fiore P; Ranieri M
    J Neurol Sci; 2017 Jul; 378():182-186. PubMed ID: 28566161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of MT10107 in post-stroke upper limb spasticity treatment: A phase I randomized controlled trial.
    Lee J; Chun MH; Ko YJ; Lee SU; Kim DY; Paik NJ
    Medicine (Baltimore); 2022 Nov; 101(44):e31367. PubMed ID: 36343044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study.
    Marciniak C; Munin MC; Brashear A; Rubin BS; Patel AT; Slawek J; Hanschmann A; Hiersemenzel R; Elovic EP
    Adv Ther; 2019 Jan; 36(1):187-199. PubMed ID: 30484117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
    Săndulescu MI; Cinteză D; Poenaru D; Potcovaru CG; Păunescu H; Coman OA
    Toxins (Basel); 2024 Mar; 16(4):. PubMed ID: 38668597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained efficacy of incobotulinumtoxina repeated injections for upper-limb post-stroke spasticity: A post hoc analysis.
    Kaňovský P; Elovic EP; Munin MC; Hanschmann A; Pulte I; Althaus M; Hiersemenzel R; Marciniak C
    J Rehabil Med; 2021 Jan; 53(1):jrm00138. PubMed ID: 33112408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study.
    Simpson DM; Gracies JM; Yablon SA; Barbano R; Brashear A;
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):380-5. PubMed ID: 18977811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploratory Randomized Double-Blind Placebo-Controlled Trial of Botulinum Therapy on Grasp Release After Stroke (PrOMBiS).
    Wallace AC; Talelli P; Crook L; Austin D; Farrell R; Hoad D; O'Keeffe AG; Marsden JF; Fitzpatrick R; Greenwood R; Rothwell JC; Werring DJ
    Neurorehabil Neural Repair; 2020 Jan; 34(1):51-60. PubMed ID: 31747825
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity.
    Ghroubi S; Alila S; Elleuch W; Ayed HB; Mhiri C; Elleuch MH
    Pan Afr Med J; 2020; 35():55. PubMed ID: 32523646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of a 15-years' experience in including shoulder muscles, when treating upper-limb spasticity post-stroke with botulinum toxin type A.
    Carvalho MP; Pinto D; Gorayeb M; Jacinto J
    Top Stroke Rehabil; 2018 Apr; 25(3):194-202. PubMed ID: 29322885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J; Bogucki A; Reclawowicz D
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.